While the specific criteria may vary based on the study protocol, some general considerations include:
Patients with advanced or metastatic carcinomas may be eligible for the TOL pilot study.
Patients who have not responded well to standard treatments, such as chemotherapy or radiation therapy, or have exhausted other treatment options, may be good candidates for the TOL pilot study.
Patients must meet certain criteria related to their overall health, including adequate organ function, performance status, and life expectancy.
Patients must provide informed consent and be willing to comply with the study protocol, including regular follow-up exams and monitoring.
Patients must be able to travel to Roatan where the pilot study is established and administered.
Our medical team will thoroughly review the information you provide to assess your suitability for the treatment and ensure your safety. Withholding or providing inaccurate information may result in disqualification from the trial or potential risks to your health and well-being.